TNF and inflammatory bowel disease: We chose infliximab for analysis among anti-TNF agent because not only is it the first and mostly widely used anti-TNF agent for IBD, but also it is a chimeric IgG monoclonal antibody that shows a higher incidence of TB compared with soluble TNF receptors.[25] Azathioprine is also the first and most widely used immunodulator for IBD.